Patients with head and neck cancer enrolled in randomized clinical trials evaluating interventions to improve outcome are much younger and have a very good performance status compared to patients seen in clinical practice, […]

Patients with head and neck cancer enrolled in randomized clinical trials evaluating interventions to improve outcome are much younger and have a very good performance status compared to patients seen in clinical practice, […]
In May, the U.S. Food and Drug Administration approved dupilumab (Dupixent) as a treatment for eosinophilic esophagitis (EoE) in adults and pediatric patients 12 years and older weighing at least […]
Barriers in care access for head and neck cancer patients can be categorized as delays in presentation, referral, and treatment, and insights gained suggest the feasibility and transferability in developing strategies for early detection.
Septorhinoplasty with spreader graft placement with and without upper lateral cartilage release provides clinically and statistically significant improvement.
A look at how procedural therapies compare to other established pharmacologic and nonpharmacologic methods in treating patients with neurogenic cough.
SARS-CoV-2 can infect human inner ear cell types, and this infection may underlie COVID-19–associated problems with hearing and balance.
Expert physician panelists at the 2022 Triological Society Combined Sections Meeting discussed the rise in HPV oropharyngeal cancer, the sometimes vexing management decisions, and the role of HPV vaccines.
Physician experts at the 2022 Triological Society Combined Sections Meeting discussed biologic therapy options for pediatrics chronic rhinosinusitis with polyps and recurrent respiratory papillomatosis.
Expert physician panelists shared their advice on the many ways of surgically repairing a hole in the eardrum at a session during the 2022 Triological Society Combined Sections Meeting.